Sheng-Hsuan Huang - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

HLA|July 16, 2026

Characterisation of the Novel HLA-C*03:02:18 Allele by Sequencing-Based Typing in a Taiwanese IndividualChia-Ling Chang, Sheng-Hsuan Huang, Chih-Wei Hsu, et al.

Optics Express|September 15, 2023

Field test of quantum key distribution with high key creation efficiencyYung-Cheng Kao, Sheng-Hsuan Huang, Chin-Hsuan Chang, et al.

The Journal of Antimicrobial Chemotherapy|April 15, 2021

SC5005 dissipates the membrane potential to kill Staphylococcus aureus persisters without detectable resistanceChieh-Hsien Lu, Chung-Wai Shiau, Yung-Chi Chang, et al.

Clinical Lymphoma, Myeloma & Leukemia|July 19, 2025

Real-World Evidence on Outcomes and Safety of Ropeginterferon Alfa-2b in Patients With Myeloproliferative Neoplasms: A Retrospective Cohort StudyYu-Sung Chang, Chieh-Yu Liu, Yu-Wen Chen, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

HLA|July 16, 2026

Characterisation of the Novel HLA-C*03:02:18 Allele by Sequencing-Based Typing in a Taiwanese IndividualChia-Ling Chang, Sheng-Hsuan Huang, Chih-Wei Hsu, et al.

Optics Express|September 15, 2023

Field test of quantum key distribution with high key creation efficiencyYung-Cheng Kao, Sheng-Hsuan Huang, Chin-Hsuan Chang, et al.

The Journal of Antimicrobial Chemotherapy|April 15, 2021

SC5005 dissipates the membrane potential to kill Staphylococcus aureus persisters without detectable resistanceChieh-Hsien Lu, Chung-Wai Shiau, Yung-Chi Chang, et al.

Clinical Lymphoma, Myeloma & Leukemia|July 19, 2025

Real-World Evidence on Outcomes and Safety of Ropeginterferon Alfa-2b in Patients With Myeloproliferative Neoplasms: A Retrospective Cohort StudyYu-Sung Chang, Chieh-Yu Liu, Yu-Wen Chen, et al.

Pageof 1